Tolerability of breast ductal lavage in women from families at high genetic risk of breast cancer

BMC Women's Health

Volumn 9, Issue , 2009, Pages

  Loud, Jennifer T ^a   Beckjord, Ellen Burke ^b   Nichols, Kathryn ^c   Peters, June ^a   Giusti, Ruthann ^d   Greene, Mark H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b RAND CORPORATION   (United States)

^c WESTAT   (United States)

^d CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; TUMOR MARKER;

ADULT; ARTICLE; BREAST CANCER; BREAST DUCTAL LAVAGE; CANCER SCREENING; CONTROLLED STUDY; CYTOLOGY; EMOTIONAL STRESS; FEMALE; GENE MUTATION; GENETIC RISK; HUMAN; HUMAN TISSUE; LAVAGE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NIPPLE ASPIRATION; NOCICEPTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT ATTITUDE; PSYCHOLOGICAL WELL BEING; ANALYSIS OF VARIANCE; BODY FLUID; BREAST; BREAST TUMOR; CYTODIAGNOSIS; GENETIC PREDISPOSITION; GENETICS; MENTAL STRESS; METHODOLOGY; MIDDLE AGED; PAIN ASSESSMENT; PATHOLOGY; PSYCHOLOGICAL ASPECT; REGRESSION ANALYSIS; TUMOR SUPPRESSOR GENE;

ADULT; ANALYSIS OF VARIANCE; BODY FLUIDS; BREAST; BREAST NEOPLASMS; CYTODIAGNOSIS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IRRIGATION; MIDDLE AGED; PAIN MEASUREMENT; REGRESSION ANALYSIS; STRESS, PSYCHOLOGICAL; TUMOR MARKERS, BIOLOGICAL;

EID: 69349102209     PISSN: None     EISSN: 14726874     Source Type: Journal    
DOI: 10.1186/1472-6874-9-20     Document Type: Article

References (42)

1. Dooley WC Ljung BM Veronesi U Cazzaniga M Elledge RM O'Shaughnessy JA Kuerer HM Hung DT Khan SA Phillips RF Ganz PA Euhus DM Esserman LJ Haffty BG King BL Kelley MC Anderson MM Schmit PJ Clark RR Kass FC Anderson BO Troyan SL Arias RD Quiring JN Love SM Page DL King EB Ductal lavage for detection of cellular atypia in women at high risk of breast cancer J Natl Cancer Inst 2001, 93(21):1624-1632. 11698566
2. Buehring GC Letscher A McGirr KM Khandhar S Che LH Nguyen CT Hackett AJ Presence of epithelial cells in nipple aspirate fluid is associated with subsequent breast cancer: A 25-year prospective study Breast Cancer Res Treat 2006, 29(1):63-70. 10.1007/s10549-005-9132-5
3. Fabian CF Kimler BF Zelles CM Klemp JR Kamel S Zeiger S Mayo MS Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model J Natl Cancer Inst 2000, 92(15):1217-1227. 10.1093/jnci/92.15.1217 10922407
4. Wrensch MR Petrakis NL King EB Miike R Mason L Chew KL Lee MM Ernster VL Hilton JF Schwitzer R Goodsond WH Hunt TK Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid Am J Epidemiol 1992, 135(2):130-41. 1536131
5. Baltzell KA Moghadassi M Rice T Sison JD Wrensch MA Epithelial cells in nipple aspirate fluid and subsequent breast cancer risk: A historic Prospective study BMC Cancer 2008, 8:75. 2292198 18366688 10.1186/ 1471-2407-8-75
6. Fabian CJ Is there a future for ductal lavage? Clin Cancer Res 2007, 13:4655-56. 10.1158/1078-0432.CCR-07-1056 17699839
7. Arun B Valero V Logan C Broglio K Rivera E Brewster A Yin G Green M Kuerer H Gogn Y Browne D Hortobagyi GN Sneige N Comparison of ductal lavage and random periareolar fine needle aspiration as tissue acquisition methods in early breast cancer prevention trials Clin Cancer Res 2007, 13(16):4943-4948. 10.1158/1078-0432.CCR-06-2732 17699874
8. Carruthers DC Chapleskie LA Flynn MB Frazier TG The use of ductal lavage as a screening tool in women at high risk for developing breast carcinoma Am J Surg 2007, 194:463-466. 10.1016/j.amjsurg.2007.06.020 17826056
9. Johnson-Maddux A Ashfaq R Cler L Cler L Naftalis E Leitch AM Hoover S Euhus DM Reproducibility of cytologic atypia in repeat nipple duct lavage Cancer 2005, 103:1129-1136. 10.1002/cncr.20884 15685620
10. Higgins SA Matloff ET Rimm DL Dziura J Haffty BG King BL Patterns of reduced nipple aspirate fluid production and ductal lavagle cellularity in women at high risk for breast cancer Breast Cancer Res and Treat 2005, 7:1017-1022. 10.1186/bcr1335
11. Patil DB Lankes HA Nayar R Nayar R Masood S Bryk M Hou N Rademaker Khan SA Reproducibility of ductal lavage cytology and cellularity over a six month interval in high risk women Breast Cancer Res and Treat 2008, 112(2):327-333. 10.1007/s10549-007-9861-8
12. Sharma P Klemp JR Simensen M Welsko CM Zalles CM Kimler BF Fabian CJ Failure of high risk women to produce nipple aspirate does not exclude detection of cytologic atypia in random periareolar needle aspiration specimens Breast Cancer Res and Treat 2004, 87:59-64. 10.1023/ B:BREA.0000041582.11586.d3
13. Visvanathan K Santor D Ali SZ Brewster A Arnold A Armstrong DK Davidson NE Helzlsouer KJ The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer - a potential tool for breast cancer risk assessment and biomarker evaluation Cancer Epidemiol Biomarkers Prev 2007, 16(5):950-955. 10.1158/1055-9965.EPI-06-0974 17507621
14. Zalles CM Kimler BF Simonsen M Clark JL Metheny T Fabian CJ Comparison of cytomorphology in specimens obtained by random periareolar fine needle aspiration and ductal lavage from women at high risk for development of breast cancer Breast Cancer Res Treat 2006, 97:191-7. 10.1007/s10549-005-9111-x 16322885
15. Abati A Greene MH Filie AC Loud J Prindiville S Danforth D Guisti RM Quantification of the cellular components of breast ductal lavage samples Diagn Ctyopathol 2006, 34:78-81. 10.1002/dc.20371
16. Danforth DN Abati A Filie A Prindiville SA Palmieri D Simon R Ried T Steeg PS Combined breast ductal lavage and ductal endoscopy for evaluation of the high-risk breast: A feasibility study J Surg Onc 2006, 94:555-64. 10.1002/jso.20650
17. Loud J Thiebaut ACM Abati AD Filie AC Nichols K Danforth D Guisti R Prindiville SA Greene MH Ductal Lavage in Women from BRCA1/2 Families: Is there a future for ductal lavage in women at increased genetic risk of breast cancer? Cancer Epidemiol Biomarkers Prev 2009, 18(4):1243-51. 10.1158/1055-9965.EPI-08-0795 19336560
18. Mitchell G Antill YC Murray W Kirk J Salisbury E Lindeman GJ Di Iulio J Milner AD Devereaux L Phillips KA Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation Breast Cancer Res 2005, 7(6):1122-31. 10.1186/bcr1348
19. Kurian AW Hartman AF Mills MA Jaffee M Sigal BM Chun NM Kingham KE Collins LC Nowels KW Plevritis SK Garber JE Ford JM Hartman AR Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: An initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage Health Expect 2006, 8:221-233. 10.1111/j.1369-7625.2005.00333.x
20. Gail MH Brinton LA Byar DP Corle DK Green SB Schairer C Mulvihill JJ Projecting individualized probabilities of developing breast cancer for white females who are being examined annually J Natl Cancer Inst 1989, 81:1879-86. 10.1093/jnci/81.24.1879 2593165
21. Euhus DM Bu D Ashfaq R Xie XJ Bian A Leitch AM Lewis CM Atypia and DNA methylation in nipple duct lavage in relation to predicted breast cancer risk Cancer Epidemiol Biomarkers Prev 2007, 16:1812-21. 10.1158/ 1055-9965.EPI-06-1034 17855699
22. Bruyninckx E Mortelmans D Van Goethem M Van Hove E Risk factors of pain in mammographic screening Soc Sci Med 1999, 49:933-941. 10.1016/ S0277-9536(99)00181-1 10468397
23. Keemers-Gels ME Groenendijk RP Heuvel van den JH Boetes C Peer PG Wobbes TH Pain experienced by women attending breast cancer screening Breast Cancer Res Treat 2000, 60:235-240. 10.1023/A:1006457520996 10930111
24. Papas M Klassen AC Pain and Discomfort Associated with Mammography Among Urban Low-Income African-American Women J Community Health 2005, 30(4):253-267. 10.1007/s10900-005-3704-5 15989208
25. Carney PA Harwood BG Weiss JE Eliassen MS Goodrich ME Factors associated with interval adherence to mammography screening in a population-based sample of New Hampshire women Cancer 2002, 95(2):219-27. 10.1002/ cncr.10681 12124819
26. Antoniou A Pharoah PD Narod S Risch HA Eyfjord JE Hopper JL Loman N Olsson H Johannsson O Borg A Pasini B Radice P Manoukian S Eccles DM Tang N Olah E Anton-Culver H Warner E Lubinski J Gronwald J Gorski B Tulinius H Thorlacius S Eerola H Nevanlinna H Syrjäkoski K Kallioniemi OP Thompson D Evans C Peto J Lalloo F Evans DG Easton DF Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies Am J Hum Genet 2003, 72:1117-113. 1180265 12677558 10.1086/375033
27. King MC Marks JH Mandell JB New York Breast Cancer Study Group Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 Science 2003, 302:643-646. 10.1126/science.1088759 14576434
28. Nathanson DL Wooster R Weber BL Breast cancer genetics: What we know and what we need Nat Med 2001, 7(5):552-6. 10.1038/87876 11329055
29. Peto J Breast cancer susceptibility-A new look at an old model Cancer Cell 2002, 1(5):411-2. 10.1016/S1535-6108(02)00079-X 12124169
30. Narod SA Brunet JS Ghadirian P Robson M Heimdal K Neuhausen SL Stoppa-Lyonnet D Lerman C Pasini B de los Rios P Weber B Lynch H Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: A case-control study Lancet 2000, 356:1876-81. 10.1016/S0140-6736(00)03258-X 11130383
31. King MC Wieand S Hale K Lee M Walsh T Owens K Tait J Ford L Dunn BK Costantino J Wickerham L Wolmark N Fisher B Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project NSABP-P1) Breast Cancer Prevention Trial JAMA 2001, 286:2251-6. 10.1001/jama.286.18.2251 11710890
32. Metcalf K Lynch HT Ghadirian P Tung N Olivotto I Warner E Olopade OI Eisen A Weber B McLennan J Sun P Foulkes WD Narod SA Contralateral breast cancer in BRCA1 and BRCA2 mutations carriers J Clin Oncol 2004, 22:2328-35. 10.1200/JCO.2004.04.033 15197194
33. Bouchard L Blancquaert I Eisinger F Foulkes WD Evans G Sobol H Julian-Reynier C Prevention and genetic testing for breast cancer: variations in medical decisions Soc Sci Med 2004, 58:1085-1096. 10.1016/ S0277-9536(03)00263-6 14723904
34. Hartman AF Daniel BL Kurian AW Mills MA Nowels KW Dirbas FM Kingham KE Chun NM Herfkens RJ Ford JM Plevritis SK Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma Cancer 2004, 100:479-489. 10.1002/cncr.11926 14745863
35. Hartmann LC Schaid DJ Woods JE Crotty TP Myers JL Arnold PG Petty PM Sellers TA Johnson JL McDonnell SK Frost MH Jenkins RB Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer N Engl J Med 1999, 340:77-84. 10.1056/NEJM199901143400201 9887158
36. Kauff N Satagopan JM Robson ME Scheuer L Hensley M Hudis CA Ellis NA Boyd J Borgen PI Barakat RR Norton L Castiel M Nafa K Offit K Risk-reducing salpingo-oophorectomy in women with BRCA1 or BRCA2 mutation N Engl J Med 2002, 346:1609-15. 10.1056/NEJMoa020119 12023992
37. Meijers-Heijboer H Brekelmans CT Menke-Pluymers M Seynaeve C Baalbergen A Burger C Crepin E Ouweland van den AW van Geel B Klijn JG Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation J Clin Oncol 2003, 21:1675-81. 10.1200/JCO.2003.09.052 12721241
38. Domcheck SM Weber BL Clinical management of BRCA1 and BRCA2 mutation carriers Oncogene 2006:255825-5831.
39. The Breast Imaging Study http://breastimaging.cancer.gov/
40. Zabora J Brintzehofe-Szoc K Jacobsen P Curbow B Piantadosi S Hooker C Owens A Derogatis L A new psychosocial screening instrument for use with cancer patients Psychosomatics 2001, 41(3):241-6. 10.1176/ appi.psy.42.3.241
41. Kramer J Velazquez I Chen BS Rosenberg PS Struewing JP Greene MH Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers J Clin Oncol 2005, 23:8629-8635. 10.1200/JCO.2005.02.9199 16314625
42. Conley B O'Shaughnessy J Prindiville S Lawrence J Chow C Jones E Merino MJ Kaiser-Kupfer MI Caruso RC Podgor M Goldspiel B Venzon D Danforth D Wu S Noone M Goldstein J Cowan KH Zujewski J Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high risk for developing invasive breast cancer J Clin Oncol 2000, 18(2):275-83. 10637240